[HTML][HTML] Heartburn's Hidden Impact: A Narrative Review Exploring Gastroesophageal Reflux Disease (GERD) as a Cardiovascular Disease Risk Factor

JJ Gries, B Chen, SS Virani, HUH Virk, H Jneid… - Journal of Clinical …, 2023 - mdpi.com
Gastroesophageal reflux disease (GERD) is a very common disease with an estimated 442
million cases worldwide. It is a well-documented independent risk factor for many …

[HTML][HTML] Inappropriate use of proton pump inhibitors increases cardiovascular events in patients with coronary heart disease

W Hu, Y Luo, X Yang - International Journal of General Medicine, 2022 - ncbi.nlm.nih.gov
Antiplatelet drugs, as the cornerstone of the treatment of coronary heart disease, control the
progression of the disease, but bring a higher risk of gastrointestinal bleeding. Relevant …

Associations between late-onset preeclampsia and the use of calcium-based antacids and proton pump inhibitors during pregnancy: a prospective cohort study

MMHJ van Gelder, P Beekers… - Clinical …, 2022 - Taylor & Francis
Purpose Preeclampsia is a leading cause of maternal morbidity and mortality. Calcium-
based antacids and proton pump inhibitors (PPIs) are commonly used during pregnancy to …

[HTML][HTML] Гастропротективная терапия у пациентов с фибрилляцией предсердий, получающих антикоагулянтную терапию

ОД Остроумова, АИ Кочетков, СВ Батюкина… - Consilium …, 2023 - cyberleninka.ru
Профилактика тромбоэмболических осложнений является главной целью у пациентов
с фибрилляцией предсердий. Для этого используют антикоагулянтную терапию, и …

Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A review

OD Ostroumova, AI Kochetkov… - Consilium …, 2023 - consilium.orscience.ru
Prevention of thromboembolic complications is the main goal in patients with atrial
fibrillation. Anticoagulant therapy is used as prophylaxis, and direct oral anticoagulants are …